Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

QR Code

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Jesse Lopes da Silva,1 Fabiana Resende Rodrigues,2 Guilherme Gomes de Mesquita,2 Priscila Valverde Fernandes,2 Luiz Claudio Santos Thuler,1 Andreia Cristina de Melo1 1Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil; 2Pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC
Format:	article
Language:	EN
Published:	Dove Medical Press 2021
Subjects:	triple-negative breast cancer neoadjuvant chemotherapy biomarkers residual burden cancer lymph node ratio. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Online Access:	https://doaj.org/article/7b85aab3ffc34272b6e335765ecc09ed
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jesse Lopes da Silva, et al.
Published: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
by: Bingqing Xia, et al.
Published: (2021)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
by: Yuanfang Xin, et al.
Published: (2021)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
by: Bin Chen, et al.
Published: (2021)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Yunhai Li, et al.
Published: (2021)

Lateral Pelvic Lymph Node Dissection for low locally advanced rectal cancer: a review
by: JU YONG CHEONG, et al.
Published: (2020)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Mo Chen, et al.
Published: (2021)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
by: Kamil D. Dalgatov, et al.
Published: (2021)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
by: Zhi Zhu, et al.
Published: (2020)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
by: Zilin Zhang, et al.
Published: (2021)

Assessing Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer Patients: A Single-Center Study in Turkey
by: Saliha Karagöz Eren, et al.
Published: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
by: Hyder T, et al.
Published: (2021)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
by: Sales ACV, et al.
Published: (2020)

Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?
by: Emil Salmo, et al.
Published: (2019)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
by: Perelmuter VM, et al.
Published: (2019)

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
by: Ziyi Liu, et al.
Published: (2021)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
by: Abdulwahab Abuderman, et al.
Published: (2020)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
by: Inna P. Ganshina, et al.
Published: (2021)

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
by: SUN Chongyuan, et al.
Published: (2021)

Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
by: Irina V. Kolyadina, et al.
Published: (2020)

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
by: Ana Julia Aguiar de Freitas, et al.
Published: (2021)

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
by: Phung HT, et al.
Published: (2020)

Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
by: Cornelis M. de Mooij, et al.
Published: (2021)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
by: Piotr Jarzemski, et al.
Published: (2020)

Lymphatic Drainage of the Breast: from Theory to Surgical Practice
by: Fregnani,José Humberto Tavares Guerreiro, et al.
Published: (2009)

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study
by: Tian X, et al.
Published: (2021)

Lymph node ratio as a predictor for minor salivary gland cancer in head and neck
by: Hidenori Suzuki, et al.
Published: (2021)

Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
by: Nadezhda A. Brish, et al.
Published: (2021)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
by: Hao Cui, et al.
Published: (2021)

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
by: Artur Lemiński, et al.
Published: (2021)

Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
by: Jinyoung Kim, et al.
Published: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
by: Zining Liu, et al.
Published: (2021)

The value of multidetector-row computed tomography in lymph node staging of gastric cancer: a preliminary Vietnamese study
by: Nguyen Van Sang, et al.
Published: (2020)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
by: Shen,Xiaogang, et al.
Published: (2017)

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
by: Lu Zhang, et al.
Published: (2021)

Triple-negative breast cancer: treatment challenges and solutions
by: Collignon J, et al.
Published: (2016)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
by: Jin Hong, et al.
Published: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
by: Fleisher B, et al.
Published: (2016)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
by: Hana Kim, et al.
Published: (2021)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
by: Peng Su, et al.
Published: (2021)